Analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for Pacific Biosciences of California in a note issued to investors on Tuesday, February 18th. Cantor Fitzgerald analyst R. Osborn now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback